Guardant Health (GH) Cash from Investing Activities (2017 - 2026)

Guardant Health has disclosed Cash from Investing Activities across 10 years of filings, most recently posting $699.4 million for Q1 2026.

• Cash from Investing Activities for Q1 2026 came in at $699.4 million, up 130.93% year-over-year; the trailing twelve-month figure through Mar 2026 was -$230.6 million (down 1809.77% YoY), and the FY2025 annual result was -$627.2 million, down 140.02% from the prior year.
• Cash from Investing Activities came in at $699.4 million for Q1 2026 at Guardant Health, up from -$905.1 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $699.4 million in Q1 2026 to a low of -$905.1 million in Q4 2025.
• The 5-year median for Cash from Investing Activities is $28.1 million (2024), against an average of $47.1 million.
• Peak annual rise in Cash from Investing Activities reached 979.11% in 2025, while the deepest fall reached 8695.13% in 2025.
• Guardant Health's Cash from Investing Activities stood at $70.6 million in 2022, then soared by 839.38% to $663.5 million in 2023, then slumped by 98.41% to $10.5 million in 2024, then plunged by 8695.13% to -$905.1 million in 2025, then surged by 177.28% to $699.4 million in 2026.
• The last three Cash from Investing Activities figures came in at $699.4 million (Q1 2026), -$905.1 million (Q4 2025), and -$14.4 million (Q3 2025), per Business Quant data.